9 results
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
phosphate binding agents ... since they are ... not able to effectively ... levels toward the normal ... #Dosing #Pharmacology
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
high-affinity, partial ... If patient is stable ... Buprenorphine Dosing ... sublingual (SL) are ... unable to take oral
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
- Comparison Table ... naloxone as a trial ... Dosing usually begins ... formulation, the dose ... common side effects are
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
in which higher doses ... margin of safety in pharmacology ... the sublingual tablet ... Pharmacokinetics #Comparison ... #Table #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
insulin requirements are ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Atrial Fibrillation ... of or increased doses ... with digoxin, are ... management #treatment #comparison ... #table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
calculations used in dosing ... insulin to their normal ... mealtime dose. ... #Pharmacology # ... Endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... neuroexam - Oral ... Insulin dependent DM ... ACEi/ARBs - Hold ... CARP, DECREASE V trials